Brachytherapy Overview

Principles

Definition

Brachytherapy is a clinical methodology within radiation oncology that involves the precise placement of radioactive sources directly within or immediately adjacent to a tumor or target tissue volume. This technique enables the delivery of a high dose of radiation locally, maximizing therapeutic effect on the malignant cells while significantly reducing dose to surrounding healthy structures, thereby enhancing the therapeutic ratio and improving treatment outcomes for various cancers.

Ontological type

Clinical Indications

Dosimetry and Planning

Delivery Techniques

Key developments

Key Figures

Time-Dose Fractionation era

Roger Dale [1] is associated with The Open University [3] in this era. His 1985 paper The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy [6], introduced the linear-quadratic dose-effect framework to fractionated regimens and provided a source-insensitive basis for comparing schedules, a keystone for time-dose planning in brachytherapy. Colin G. Orton [2] is affiliated with Brown University [4] and New York University [5] during this era. His work includes A simplification in the use of the NSD concept in practical radiotherapy [7] and Time-dose factors (TDFs) in brachytherapy [8], which supplied practical metrics to standardize planning and facilitate cross-modality comparisons in this era.

Dosimetry Standardization Era era

Richard Pötter [1], affiliated with Radboud University Nijmegen [3] and Heidelberg University [4], emerged as a leading architect of brachytherapy dosimetry during this era. His key contributions include the 2006 GYN GEC ESTRO recommendations on concepts and 3D dose-volume parameters in cervix cancer brachytherapy [7], the 2007 MRI-assisted dose-volume adaptation and dose escalation study [8], and the Vienna applicator design and dosimetric results [9], collectively advancing 3D image-based planning and standardizing dose metrics. Christian Kirisits [2], affiliated with the Medical University of Vienna [5] and the University of Vienna [6], co-authored foundational work on 3D image-based planning, including the 2006 recommendations [7], the 2007 MRI-assisted dose-volume adaptation [8], and the Vienna applicator paper [9]. These contributions were crucial for establishing reproducible dose calculations, 3D planning foundations, and cross-center comparability that anchored multicenter evaluation of brachytherapy interventions during the Dosimetry Standardization Era.

MRI-Guided Adaptive Era era

Christian Kirisits [1] is associated with Harvard University [3] and the Medical University of Vienna [4] during the MRI-Guided Adaptive Era. His key contributions include MRI-guided adaptive brachytherapy in locally advanced cervical cancer as demonstrated in EMBRACE-I [6], recommendations on 3D image-based treatment planning and applicator reconstruction [7], and dose-effect work on late rectal and urinary bladder toxicity [8], which collectively advanced precision and safety in this era. Richard Pötter [2] is affiliated with the Institute of Cancer Research [5] and Harvard University [3] during this era. His contributions include leading the EMBRACE-I multicentre study [6], assessing late side effects of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation [9], and reinforcing dose-effect understanding in cervical cancer planning [8], driving cross-center reproducibility and toxicity-reduction strategies.